RevelAi Health and Zimmer Biomet Holdings, have announced a multi-year co-marketing agreement to promote generative artificial intelligence (AI)-powered solutions aimed at advancing value-based orthopedic care and health equity.

Zimmer Biomet will commercialize RevelAi Health's platform for patient care management, provider dashboards, and future products.

CEO of RevelAi Health and orthopedic trauma surgeon at Duke University School of Medicine, highlighted the transformative potential of AI in streamlining clinical workflows and addressing socio-demographic disparities.

AI-driven care model offers personalized and timely patient care, reducing clinician burnout. The collaboration with Zimmer Biomet marks a significant stride towards ensuring equitable healthcare delivery.

RevelAi Health specializes in SaaS health technology, using generative AI to support healthcare providers in transitioning to value-based care and meeting CMS requirements such as Patient Reported Outcome measures and Social Drivers of Health Screening (SDOH).

Their patient care management system integrates text messaging and clinician-guided voice agents to optimize care workflows and enhance patient engagement.

Commitment to making orthopedic care more accessible and addressing both clinical and social needs within communities.

Expressed confidence that partnering with RevelAi Health will leverage their combined technological innovations to address the healthcare needs of underserved populations and help clinicians achieve better value-based outcomes.

 

 

 

 

Source: prnewswire.com

Report Abuse